-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED Launches Phase III Trial of Surufatinib and Camrelizumab Combo for Metastatic Pancreatic Cancer

路透·01/05/2026 00:00:18

登錄查看新聞詳情